Atea Pharmaceuticals(AVIR)
Search documents
Atea Pharmaceuticals(AVIR) - 2022 Q2 - Earnings Call Transcript
2022-08-09 01:19
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Jonae Barnes - Senior Vice President of Investor Relations & Corporate Communications Jean-Pierre Sommadossi - Chief Executive Officer & Founder Janet Hammond - Chief Development Officer Andrea Corcoran - Chief Financial Officer & Executive President of Legal John Vavricka - Chief Commercial Officer Conference Call Participants Tim Lugo - William Blair Nik Gasic - SVB Securities Operator ...
Atea Pharmaceuticals(AVIR) - 2022 Q1 - Earnings Call Transcript
2022-05-10 17:43
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Jean-Pierre Sommadossi - Founder & CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO & EVP, Legal John Vavricka - Chief Commercial Officer Jonae Barnes - SVP, IR & Corporate Communications Conference Call Participants Hannah Colgan - JPMorgan Umer Raffat - Evercore Nik Gasic - SVB Securities Jonathan Miller - Evercore Operator Good morning, and welcome to the Atea Pharmace ...
Atea Pharmaceuticals(AVIR) - 2021 Q4 - Earnings Call Transcript
2022-03-01 03:28
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Jonae Barnes - SVP, IR and Corporate Communications Jean-Pierre Sommadossi - Founder and CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO and EVP, Legal John Vavricka - Chief Commercial Officer Conference Call Participants Matthew Harrison - Morgan Stanley Lachlan Hanbury-Brown - William Blair Roanna Ruiz - SVB Leerink Operator Good afternoon, ladies and gentlemen we ...